Pharmaceutical impurities: Analytical, toxicological and regulatory perspectives
Assuring quality of drugs by monitoring impurities
Strategies for the investigation and control of process-related impurities in drug substances
The role of degradant profiling in active pharmaceutical ingredients and drug products
Toxicological overview of impurities in pharmaceutical products
Progress in QSAR toxicity screening of pharmaceutical impurities and other FDA regulated products
Impurities in generic pharmaceutical development
Pharmaceutical impurities: Regulatory perspective for Abbreviated New Drug Applications